Table 3.
Clinical characteristics of FSS patients with Stage II or III
| No. | Age (year) | Initial surgery | Stage | HT | Grade | PBC | tr (month) | RS | tf (month) | Status |
| 1 | 29 | USO+OM | IIIc | Serous | NG | Yes | 22 | Rectum | 23 | DOD |
| 2 | 33 | UC | IIIa | Clear cell | NG | Yes* | 7 | Ovary | 9 | DOD |
| 3 | 37 | BC | IIIc | Mucinous | 1 | Yes* | 26 | PC | 31 | AWD |
| 4 | 28 | USO+OM | IIIc | Endometrioid | 1 | Yes | NR | NR | 56 | AWD |
| 5 | 29 | USO+CC | IIIa | Serous | 1 | Yes* | 24 | PC | 58 | NED |
| 6 | 24 | USO | IIIc | Mixed | 1 | Yes | NR | NR | 15 | AWD |
| 7 | 21 | USO+OM+PLND/PALND | IIIa | Mucinous | 2 | Yes | NR | NR | 53 | DOD |
| 8 | 30 | UC+BO+OM | IIIc | Endometrioid | 2 | Yes | NR | NR | 35 | NED |
| 9 | 37 | USO+OM+PLND/PALND | IIIc | Endometrioid | 2 | Yes | 24 | PC | 36 | DOD |
| 10 | 33 | USO+BO | II | Serous | 1 | Yes | NR | NR | 50 | NED |
| 11 | 29 | USO+OM | IIIa | Endometrioid | 1 | Yes | NR | NR | 48 | NED |
| 12 | 31 | USO+OM+PLND/PALND | IIIc | Mixed | 1 | Yes | NR | NR | 52 | NED |
HT: histological type; PBC: platinum-based chemotherapy; t r: time to recurrence; RS: recurrence site; t f: follow-up time; USO: unilateral salpingo-oophorectomy; OM: omentectomy; UC: unilateral cystectomy; BC: bilateral cystectomy; CC: contralateral cystectomy; PLND/PALND: pelvic/para-aortic lymph nodes dissection or biopsy; BO: biopsy from the opposite ovarian; NG: not graded; NR: no recurrence; PC: peritoneal cavity recurrence; DOD: died of the disease; AWD: alive with the disease; NED: no evidence of the disease
*
Non-standard platinum-based chemotherapy